Overview

Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Type 2 Diabetes Mellitus (T2DM) represents a model of endothelial dysfunction, where chronic nitric oxide deprivation, hyperglycaemia and hyperinsulinemia and fibrogenic mediators lead to cardiovascular remodelling associated with diabetic cardiomyopathy and in consequence to secondary complications of diabetes. Specific anti-oxidative and anti-fibrotic therapies are not currently available. Sildenafil (Viagra) has demonstrated the capability of significantly improving endothelial dysfunction and cardiac fibrosis in experimental animal models. The purpose of the present study is performed to establish the effect of chronic high dose sildenafil treatment on heart performance in diabetic subjects.
Phase:
Phase 4
Details
Lead Sponsor:
University of Roma La Sapienza
Treatments:
Sildenafil Citrate